1. Accueil >
  2. Novo Nordisk A/S: CHMP endorses EU label update of Saxenda® based on the LEADER trial >
Nasdaq

Novo Nordisk A/S: CHMP endorses EU label update of Saxenda® based on the LEADER trial

22-06-2017


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via GlobeNewswire

HUG#2115243